Skip To Main Content
Karin Jooss on Muck Rack

Karin Jooss

San Diego
As seen in: Nature, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Karin

Contact Karin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults - Nature Communications

|
By Christine Palmer, Karin Jooss, Melissa A. Kachura, Jason R. Jaroslavsky, Martina Marrali, Milana Egorova, Pedro Garbes
| Nature Verified
Abstract SARS-CoV-2 has resulted in high levels of morbidity and mortality world-wide, and severe complications can occur in older populations. Humoral immunity induced by authorized vaccines wanes within 6 months, and frequent boosts may only offer transient protection. GRT-R910 is an investigational self-amplifying mRNA (samRNA)-based SARS-CoV-2 vaccine delivering full-length Spike and selected conserved non-Spike T cell epitopes.
Open in Who Shared Issue with article?

Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different

|
By Chung-Han Lee, Roman Yelensky, Karin Jooss, Timothy Chan
| Cell Press Verified
Prehn R.T. Main J.M. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 1957; 18: 769-778 Coulie P.G. et al. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J. Immunother. Emphas. Tumor Immunol. 1993; 14: 104-109 van der Bruggen P. et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol. 1994; 24: 2134-2140 Chen Y.T. et al.
Open in Who Shared Issue with article?
See all 2 articles